# LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
> **ANDA091617** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC PHARMS LTD · Approved 2012-02-17
## Drug
- **FDA Application Number:** ANDA091617
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
- **Generic name:** LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC PHARMS LTD
- **Manufacturer:** Alembic Pharmaceuticals Limited
- **First approval:** 2012-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091617)
---
*MORVS · CC0 1.0*